Methylene amine substituted arylindenopyrimidines as potent adenosine A sub(2A)/A sub(1) antagonists

A novel series of arylindenopyrimidines were identified as A sub(2A) and A sub(1) receptor antagonists. The series was optimized for in vitro activity by substituting the 8- and 9-positions with methylene amine substituents. The compounds show excellent activity in mouse models of Parkinson's d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2010-05, Vol.20 (9), p.2864-2867
Hauptverfasser: Shook, Brian C, Rassnick, Stefanie, Hall, Daniel, Rupert, Kenneth C, Heintzelman, Geoffrey R, Hansen, Kristen, Chakravarty, Devraj, Bullington, James L, Scannevin, Robert H, Magliaro, Brian, Westover, Lori, Carroll, Karen, Lampron, Lisa, Russell, Ronald, Branum, Shawn, Wells, Kenneth, Damon, Sandra, Youells, Scott, Li, Xun, Osbourne, Mel, Demarest, Keith, Tang, Yuting, Rhodes, Kenneth, Jackson, Paul F
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2867
container_issue 9
container_start_page 2864
container_title Bioorganic & medicinal chemistry letters
container_volume 20
creator Shook, Brian C
Rassnick, Stefanie
Hall, Daniel
Rupert, Kenneth C
Heintzelman, Geoffrey R
Hansen, Kristen
Chakravarty, Devraj
Bullington, James L
Scannevin, Robert H
Magliaro, Brian
Westover, Lori
Carroll, Karen
Lampron, Lisa
Russell, Ronald
Branum, Shawn
Wells, Kenneth
Damon, Sandra
Youells, Scott
Li, Xun
Osbourne, Mel
Demarest, Keith
Tang, Yuting
Rhodes, Kenneth
Jackson, Paul F
description A novel series of arylindenopyrimidines were identified as A sub(2A) and A sub(1) receptor antagonists. The series was optimized for in vitro activity by substituting the 8- and 9-positions with methylene amine substituents. The compounds show excellent activity in mouse models of Parkinson's disease when dosed orally.
doi_str_mv 10.1016/j.bmcl.2010.03.042
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_745710803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>745710803</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_7457108033</originalsourceid><addsrcrecordid>eNqNi72OwjAQhF0cEuHnBa5yd1CQrBMfPyVCIBq6K65DJlnujBw7ZDdF3p5E8AA0M6OZb4T4VBArUMvkFl_K3MUpdAVkMej0Q0SwWcJivdG_QzEiugEoDVpHojgh_7cOPUpT2k6puRBbbhgLaerWWV-gD1Vb29IWHUDSkKwCo2dp-on617b_zdLtPHkmNZfGs_kL3hLTRAyuxhFOXz4WX4f9z-64qOpwb5D4XFrK0TnjMTR0XunvlYI1ZNn75AMaPk-B</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>745710803</pqid></control><display><type>article</type><title>Methylene amine substituted arylindenopyrimidines as potent adenosine A sub(2A)/A sub(1) antagonists</title><source>Elsevier ScienceDirect Journals</source><creator>Shook, Brian C ; Rassnick, Stefanie ; Hall, Daniel ; Rupert, Kenneth C ; Heintzelman, Geoffrey R ; Hansen, Kristen ; Chakravarty, Devraj ; Bullington, James L ; Scannevin, Robert H ; Magliaro, Brian ; Westover, Lori ; Carroll, Karen ; Lampron, Lisa ; Russell, Ronald ; Branum, Shawn ; Wells, Kenneth ; Damon, Sandra ; Youells, Scott ; Li, Xun ; Osbourne, Mel ; Demarest, Keith ; Tang, Yuting ; Rhodes, Kenneth ; Jackson, Paul F</creator><creatorcontrib>Shook, Brian C ; Rassnick, Stefanie ; Hall, Daniel ; Rupert, Kenneth C ; Heintzelman, Geoffrey R ; Hansen, Kristen ; Chakravarty, Devraj ; Bullington, James L ; Scannevin, Robert H ; Magliaro, Brian ; Westover, Lori ; Carroll, Karen ; Lampron, Lisa ; Russell, Ronald ; Branum, Shawn ; Wells, Kenneth ; Damon, Sandra ; Youells, Scott ; Li, Xun ; Osbourne, Mel ; Demarest, Keith ; Tang, Yuting ; Rhodes, Kenneth ; Jackson, Paul F</creatorcontrib><description>A novel series of arylindenopyrimidines were identified as A sub(2A) and A sub(1) receptor antagonists. The series was optimized for in vitro activity by substituting the 8- and 9-positions with methylene amine substituents. The compounds show excellent activity in mouse models of Parkinson's disease when dosed orally.</description><identifier>ISSN: 0960-894X</identifier><identifier>DOI: 10.1016/j.bmcl.2010.03.042</identifier><language>eng</language><ispartof>Bioorganic &amp; medicinal chemistry letters, 2010-05, Vol.20 (9), p.2864-2867</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Shook, Brian C</creatorcontrib><creatorcontrib>Rassnick, Stefanie</creatorcontrib><creatorcontrib>Hall, Daniel</creatorcontrib><creatorcontrib>Rupert, Kenneth C</creatorcontrib><creatorcontrib>Heintzelman, Geoffrey R</creatorcontrib><creatorcontrib>Hansen, Kristen</creatorcontrib><creatorcontrib>Chakravarty, Devraj</creatorcontrib><creatorcontrib>Bullington, James L</creatorcontrib><creatorcontrib>Scannevin, Robert H</creatorcontrib><creatorcontrib>Magliaro, Brian</creatorcontrib><creatorcontrib>Westover, Lori</creatorcontrib><creatorcontrib>Carroll, Karen</creatorcontrib><creatorcontrib>Lampron, Lisa</creatorcontrib><creatorcontrib>Russell, Ronald</creatorcontrib><creatorcontrib>Branum, Shawn</creatorcontrib><creatorcontrib>Wells, Kenneth</creatorcontrib><creatorcontrib>Damon, Sandra</creatorcontrib><creatorcontrib>Youells, Scott</creatorcontrib><creatorcontrib>Li, Xun</creatorcontrib><creatorcontrib>Osbourne, Mel</creatorcontrib><creatorcontrib>Demarest, Keith</creatorcontrib><creatorcontrib>Tang, Yuting</creatorcontrib><creatorcontrib>Rhodes, Kenneth</creatorcontrib><creatorcontrib>Jackson, Paul F</creatorcontrib><title>Methylene amine substituted arylindenopyrimidines as potent adenosine A sub(2A)/A sub(1) antagonists</title><title>Bioorganic &amp; medicinal chemistry letters</title><description>A novel series of arylindenopyrimidines were identified as A sub(2A) and A sub(1) receptor antagonists. The series was optimized for in vitro activity by substituting the 8- and 9-positions with methylene amine substituents. The compounds show excellent activity in mouse models of Parkinson's disease when dosed orally.</description><issn>0960-894X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNi72OwjAQhF0cEuHnBa5yd1CQrBMfPyVCIBq6K65DJlnujBw7ZDdF3p5E8AA0M6OZb4T4VBArUMvkFl_K3MUpdAVkMej0Q0SwWcJivdG_QzEiugEoDVpHojgh_7cOPUpT2k6puRBbbhgLaerWWV-gD1Vb29IWHUDSkKwCo2dp-on617b_zdLtPHkmNZfGs_kL3hLTRAyuxhFOXz4WX4f9z-64qOpwb5D4XFrK0TnjMTR0XunvlYI1ZNn75AMaPk-B</recordid><startdate>20100501</startdate><enddate>20100501</enddate><creator>Shook, Brian C</creator><creator>Rassnick, Stefanie</creator><creator>Hall, Daniel</creator><creator>Rupert, Kenneth C</creator><creator>Heintzelman, Geoffrey R</creator><creator>Hansen, Kristen</creator><creator>Chakravarty, Devraj</creator><creator>Bullington, James L</creator><creator>Scannevin, Robert H</creator><creator>Magliaro, Brian</creator><creator>Westover, Lori</creator><creator>Carroll, Karen</creator><creator>Lampron, Lisa</creator><creator>Russell, Ronald</creator><creator>Branum, Shawn</creator><creator>Wells, Kenneth</creator><creator>Damon, Sandra</creator><creator>Youells, Scott</creator><creator>Li, Xun</creator><creator>Osbourne, Mel</creator><creator>Demarest, Keith</creator><creator>Tang, Yuting</creator><creator>Rhodes, Kenneth</creator><creator>Jackson, Paul F</creator><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20100501</creationdate><title>Methylene amine substituted arylindenopyrimidines as potent adenosine A sub(2A)/A sub(1) antagonists</title><author>Shook, Brian C ; Rassnick, Stefanie ; Hall, Daniel ; Rupert, Kenneth C ; Heintzelman, Geoffrey R ; Hansen, Kristen ; Chakravarty, Devraj ; Bullington, James L ; Scannevin, Robert H ; Magliaro, Brian ; Westover, Lori ; Carroll, Karen ; Lampron, Lisa ; Russell, Ronald ; Branum, Shawn ; Wells, Kenneth ; Damon, Sandra ; Youells, Scott ; Li, Xun ; Osbourne, Mel ; Demarest, Keith ; Tang, Yuting ; Rhodes, Kenneth ; Jackson, Paul F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_7457108033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shook, Brian C</creatorcontrib><creatorcontrib>Rassnick, Stefanie</creatorcontrib><creatorcontrib>Hall, Daniel</creatorcontrib><creatorcontrib>Rupert, Kenneth C</creatorcontrib><creatorcontrib>Heintzelman, Geoffrey R</creatorcontrib><creatorcontrib>Hansen, Kristen</creatorcontrib><creatorcontrib>Chakravarty, Devraj</creatorcontrib><creatorcontrib>Bullington, James L</creatorcontrib><creatorcontrib>Scannevin, Robert H</creatorcontrib><creatorcontrib>Magliaro, Brian</creatorcontrib><creatorcontrib>Westover, Lori</creatorcontrib><creatorcontrib>Carroll, Karen</creatorcontrib><creatorcontrib>Lampron, Lisa</creatorcontrib><creatorcontrib>Russell, Ronald</creatorcontrib><creatorcontrib>Branum, Shawn</creatorcontrib><creatorcontrib>Wells, Kenneth</creatorcontrib><creatorcontrib>Damon, Sandra</creatorcontrib><creatorcontrib>Youells, Scott</creatorcontrib><creatorcontrib>Li, Xun</creatorcontrib><creatorcontrib>Osbourne, Mel</creatorcontrib><creatorcontrib>Demarest, Keith</creatorcontrib><creatorcontrib>Tang, Yuting</creatorcontrib><creatorcontrib>Rhodes, Kenneth</creatorcontrib><creatorcontrib>Jackson, Paul F</creatorcontrib><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shook, Brian C</au><au>Rassnick, Stefanie</au><au>Hall, Daniel</au><au>Rupert, Kenneth C</au><au>Heintzelman, Geoffrey R</au><au>Hansen, Kristen</au><au>Chakravarty, Devraj</au><au>Bullington, James L</au><au>Scannevin, Robert H</au><au>Magliaro, Brian</au><au>Westover, Lori</au><au>Carroll, Karen</au><au>Lampron, Lisa</au><au>Russell, Ronald</au><au>Branum, Shawn</au><au>Wells, Kenneth</au><au>Damon, Sandra</au><au>Youells, Scott</au><au>Li, Xun</au><au>Osbourne, Mel</au><au>Demarest, Keith</au><au>Tang, Yuting</au><au>Rhodes, Kenneth</au><au>Jackson, Paul F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methylene amine substituted arylindenopyrimidines as potent adenosine A sub(2A)/A sub(1) antagonists</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><date>2010-05-01</date><risdate>2010</risdate><volume>20</volume><issue>9</issue><spage>2864</spage><epage>2867</epage><pages>2864-2867</pages><issn>0960-894X</issn><abstract>A novel series of arylindenopyrimidines were identified as A sub(2A) and A sub(1) receptor antagonists. The series was optimized for in vitro activity by substituting the 8- and 9-positions with methylene amine substituents. The compounds show excellent activity in mouse models of Parkinson's disease when dosed orally.</abstract><doi>10.1016/j.bmcl.2010.03.042</doi></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2010-05, Vol.20 (9), p.2864-2867
issn 0960-894X
language eng
recordid cdi_proquest_miscellaneous_745710803
source Elsevier ScienceDirect Journals
title Methylene amine substituted arylindenopyrimidines as potent adenosine A sub(2A)/A sub(1) antagonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A53%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methylene%20amine%20substituted%20arylindenopyrimidines%20as%20potent%20adenosine%20A%20sub(2A)/A%20sub(1)%20antagonists&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Shook,%20Brian%20C&rft.date=2010-05-01&rft.volume=20&rft.issue=9&rft.spage=2864&rft.epage=2867&rft.pages=2864-2867&rft.issn=0960-894X&rft_id=info:doi/10.1016/j.bmcl.2010.03.042&rft_dat=%3Cproquest%3E745710803%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=745710803&rft_id=info:pmid/&rfr_iscdi=true